Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics
Rim enhancement, CBD dilation on contrast-enhanced MRI and higher CA19-9 level are promising radiological and clinical factors for identifying SMAD4-mutated PDAC.
Authors
- Mengsu Zeng (ORCID: https://orcid.org/0000-0001-5414-2600)
- Tianzhu Yu
- Haitao Sun
- Xiaolin Wang (ORCID: https://orcid.org/0000-0003-2205-2103)
- Jianjun Zhou (ORCID: https://orcid.org/0000-0001-9898-7285)
- Jianbo Li (ORCID: https://orcid.org/0000-0001-7916-0944)
- Xiang Li (ORCID: https://orcid.org/0000-0002-1575-6834)
- Cheng Wang (ORCID: https://orcid.org/0000-0001-6075-2878)
- Zhina Li (ORCID: https://orcid.org/0000-0003-2327-9940)
- Xingxing Wang (ORCID: https://orcid.org/0000-0002-9281-2043)
Institutions
- Shanghai Medical College of Fudan University (CN)
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Linyi People's Hospital (CN)
- Shanghai Xuhui Central Hospital (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- BMC Medical Imaging
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1186/s12880-024-01539-3
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- China Postdoctoral Science Foundation